Literature DB >> 11497387

Major depression and demoralization in cancer patients: diagnostic and treatment considerations.

A F Angelino1, G J Treisman.   

Abstract

Major depression and demoralization are very common in patients with cancer. A discussion of the diagnostic specificity of major depression and demoralization (also known as adjustment disorder) is presented here, followed by a review of some effects of comorbid depression and cancer. Finally, there are a brief review of studies of antidepressant pharmacotherapy in cancer patients, a treatment algorithm for antidepressant therapy, and suggestions for treatment of demoralization.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11497387     DOI: 10.1007/s005200000195

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  21 in total

1.  Most patients depressed by cancer do not need drugs.

Authors:  Ulrich S Schuler
Journal:  BMJ       Date:  2002-11-09

2.  Demoralization, anhedonia and grief in patients with severe physical illness.

Authors:  David M Clarke; David W Kissane; Tom Trauer; Graeme C Smith
Journal:  World Psychiatry       Date:  2005-06       Impact factor: 49.548

3.  Neuropsychological disorders in non-central nervous system cancer: a review of objective cognitive impairment, depression, and related rehabilitation options.

Authors:  Fulvia Di Iulio; Luca Cravello; Jacob Shofany; Stefano Paolucci; Carlo Caltagirone; Giovanni Morone
Journal:  Neurol Sci       Date:  2019-05-02       Impact factor: 3.307

4.  Slow versus standard up-titration of paroxetine for the treatment of depression in cancer patients: a pilot study.

Authors:  Laura Amodeo; Lorys Castelli; Paolo Leombruni; Daniela Cipriani; Alessia Biancofiore; Riccardo Torta
Journal:  Support Care Cancer       Date:  2011-03-15       Impact factor: 3.603

5.  Depressive symptom patterns and their consequences for diagnosis of affective disorders in cancer patients.

Authors:  Katrin Reuter; Simone Raugust; Jürgen Bengel; Martin Härter
Journal:  Support Care Cancer       Date:  2004-10-09       Impact factor: 3.603

6.  Pancreatic cancer and depression: myth and truth.

Authors:  Martina Mayr; Roland M Schmid
Journal:  BMC Cancer       Date:  2010-10-20       Impact factor: 4.430

7.  An open-label long-term naturalistic study of mirtazapine treatment for depression in cancer patients.

Authors:  Mehmet A Ersoy; Aysin M Noyan; Hayriye Elbi
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

8.  Psychiatric morbidity among cancer patients and awareness of illness.

Authors:  Figen Culha Atesci; Bahar Baltalarli; Nalan Kalkan Oguzhanoglu; Filiz Karadag; Osman Ozdel; Nursel Karagoz
Journal:  Support Care Cancer       Date:  2004-01-28       Impact factor: 3.603

9.  Socio-demographic and clinical features associated with demoralization in medically ill in-patients.

Authors:  Carlo Marchesi; Carlo Maggini
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-07-11       Impact factor: 4.328

10.  Age and sex dependencies of anxiety and depression in cardiologic patients compared with the general population.

Authors:  Andreas Hinz; Jörg Kittel; Marthin Karoff; Reinhold Schwarz
Journal:  Psychosoc Med       Date:  2004-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.